40 Search Results for Lymphoma

Optimizing Treatment of Peripheral T-cell Lymphoma

Long-term survival in patients with aggressive peripheral T-cell lymphoma (PTCL) is generally poor, no clear consensus exists on optimal initial therapy, according to a new study.


Treatment Options Multiply for Cutaneous T-cell Lymphoma

After decades on the sidelines, research in cutaneous T-cell lymphoma (CTCL) has exploded in recent years, bringing patients with this rare disease new opportunities for treatment.

Study Looks for Patterns in Lymphoma Relapse

PORTLAND, OR—High response rates can be achieved with first-line high-dose methotrexate (HD-MTX) based regimens for primary central nervous system lymphoma (PCNSL), but many patients relapse within two years of diagnosis, according to a study in... View Article

Lymphoma, Other Cancers Linked to HCV

Hepatitis C virus (HCV) infection is known to cause hepatocellular carcinoma (HCC) and subtypes of non-Hodgkin lymphoma (NHL).

Impetigo, Psoriasis Might Increase Cutaneous T-Cell Lymphoma Risk

Recent research has focused on some etiological factors to help predict who is at risk for developing cutaneous T-cell lymphoma (CTCL), which occurs disproportionately in veterans.

Genomic Research Identifies Possible Therapeutic Targets for Cutaneous T-Cell Lymphoma

Presumptively caused by Agent Orange exposure, cutaneous T-cell lymphoma occurs disproportionately among male veterans. Complicating the clinical approach, the disorders comprising CTCL are similar but differ greatly in response to therapy. New genomic research on the rare cancer, however, is holding out promise for better, more-customized treatment.

Lymphoma Survivors Should Be Monitored for Melanoma

ROCKVILLE, MD — While previous studies have reported that survivors of non-Hodgkin lymphoma (NHL) have an increased risk of developing cutaneous melanoma, risks associated with specific treatments and immune-related risk factors have not been quantified.To... View Article

Disrupted Metabolism Affects Lymphoma Development

SAN ANTONIO — New research directly links disrupted metabolism to a common and often fatal type of lymphoma, according to an article in Nature Communications.1“The link between metabolism and cancer has been proposed or inferred... View Article

VA Tops in Experience With Rare Lymphomas, Looks for More Effective Treatments

As the healthcare system with the most experience treating older men, the VA has special expertise in treating uncommon diseases that plague them, such as peripheral T-cell lymphoma. The current challenge for clinicians is to... View Article

Rare Lymphoma Challenges VA Clinicians from Diagnosis to Treatment

An estimated 5-10% of all cutaneous T-cell lymphoma (CTCL) diagnosed each year occurs in veterans treated by the VA. The cancer, classified as presumptively caused by Agent Orange exposure, is notoriously difficult to diagnose and... View Article

Cognitive Dysfunction

Cognitive Dysfunction Affects Blood Cancer Survival

BOSTON — With an aging population, cognitive impairment is increasingly common. The question raised by a new study was what effect that has on survival for older patients with hematologic cancers.

Survey Results Add to Information About ECP Treatment for CTCL

LEBANON, NH — Extracorporeal photopheresis (ECP) is a leukapheresis-based therapeutic procedure that has been approved by the Food and Drug Administration (FDA) for the treatment of advanced cutaneous T-cell lymphoma (CTCL) since 1988. In ECP,... View Article

New Treatment Option Extends CTCL Progression Free Survival

STANFORD, CA — Patients with cutaneous T-cell lymphoma (CTCL) might have a promising new treatment option, according to a study presented at a recent conference. In a presentation at the 2017 American Society of Hematology... View Article

Agent Orange Exposure Doesn’t Reduce CLL Survival

MINNEAPOLIS—Exposure to Agent Orange was not associated with either poor prognostic factors or shortened overall survival in a large veteran population with chronic lymphocytic leukemia (CLL), even though it is associated with development of the... View Article

Agent Orange

VA Makes Decision on Expansion of Agent Orange Presumptive Conditions

VA Secretary David Shulkin, MD, said he has made a decision on the expansion of the list of presumptive conditions for Agent Orange compensation and has passed it on to the next step in the process.

Living With a Mystery Disease: One Woman’s Story

At 31, Susan Thornton developed an itchy rash around her waist.

Despite Criticism of Federal Medicine, Innovation Thrives at VA, MHS

By Brenda L. Mooney Editorial Director ATLANTA — When it comes to American politics, we certainly live in contentious – if not always interesting – times. One of those hot-button issues is a so-called single-payer... View Article

Protein Can Help Identify Which Rashes Are Early Mycosis Fungoides

Chronic rash in a sun-protected area that doesn’t respond to topical treatment likely needs to be evaluated for mycosis fungoides, the most common variant of cutaneous T-cell lymphoma. Now, a new VA study reports that... View Article


New Rule Allows Benefits for Some Camp Lejeune Veterans

Thousands of veterans who were exposed to contaminants at Camp Lejeune will become eligible for automatic disability compensation if they have been diagnosed with eight diseases linked with toxins in the water supply.

VA Pushes for Presumptive Coverage for Camp Lejeune Veterans

Under a newly-proposed regulation, thousands of veterans could have an easier time obtaining disability benefits for certain conditions linked to service at Camp Lejeune.